Replies to post #510433 on NorthWest Biotherapeutics Inc (NWBO)

[LearningEveryTrade]

Branster, I think his is why we hear lots of $5, $10,15$ price targets for NWBO... market cap wise, NVCR is about 8B now... at a high roughly, call it 20B, that makes NWBO $6/$16...given share count.

Now, 5 years from now... wow... how many other trial readouts can we be seeing... Combos/Non-Operable/Breast/Lung/PIP

AND, what can Flaskworks do as a licensed tech ??

Endless...

[biosectinvestor]

True, but it's all about market cap, and I think NWBO's ultimate market cap, as a fully operating company, on a long-term basis, potentially serving many more types of cancer patients, has a much larger potential in the long-term as a systemic, immunotherapy.